Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamune in Bilateral Geographic Atrophy (SIRGA2)
NCT01445548Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Sep 2011
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in geographic atrophy (GA), age-related macular degeneration (AMD), sponsored by National Eye Institute. Started Sep 2011; status: completed.
02
Drugs
sirolimus
03
Conditions
geographic atrophy (GA)age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT01445548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01445548.